Search

everythinglearnresearchcommunity

for

Search:↓

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Low-Level Light Therapy is effective for skin rejuvenation, wound healing, and hair growth, with mild side effects.

Certain IL-18 gene variations may increase the risk of alopecia areata.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Combination therapies might work better for some vitiligo patients, but results vary.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Phospholipase A2 enzymes play key roles in skin health and disease.

TLR4 is important in aging-related diseases and could be a new treatment target.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Histone modification is key in treating chronic inflammatory skin diseases.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.